Evotec Priority Reset to Focus on Profitable Growth

 

• FINANCIAL RESULTS FOR 2023 FULLY MET UPDATED GUIDANCE
• PRIORITY RESET TO PROFITABLE GROWTH: SIZE & FOOTPRINT ADJUSTMENTS TO DRIVE EXPECTED ANNUALISED EBITDA IMPROVEMENT GREATER THAN € 40 M
• EVOTEC’S REPORTING STRUCTURE WILL CHANGE TO BUSINESS SEGMENTS “SHARED R&D” AND “JUST - EVOTEC BIOLOGICS” STARTING Q1 2024

https://www.accesswire.com/856024/evotec-presents-fiscal-year-2023-results-and-announces-priority-reset-to-focus-on-profitable-growth